We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRXB.U
3226
DELISTED
Forest Road Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
FRXB.U
– –
-617,929
Closed -$6.16M
FSRXU
3227
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
– –
-100,000
Closed -$996K
CCVI.U
3228
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
– –
-25,000
Closed -$252K
CFFEU
3229
DELISTED
CF Acquisition Corp. VIII Unit
CFFEU
– –
-793,346
Closed -$7.87M
APGB.U
3230
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
– –
-1,003,720
Closed -$10M
APRN
3231
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
– –
-2,388
Closed -$181K
ICPT
3232
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-76,723
Closed -$1.77M
PRPC.U
3233
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
– –
-156,246
Closed -$1.56M
AAC.U
3234
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
– –
-1,355,800
Closed -$13.6M
DEN
3235
DELISTED
Denbury Inc.
DEN
– –
-111,673
Closed -$5.35M
TRCA.U
3236
DELISTED
Twin Ridge Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TRCA.U
– –
-506,188
Closed -$5.04M
MDNA
3237
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
– –
-80,401
Closed -$328K
RAD
3238
DELISTED
Rite Aid Corporation
RAD
– –
-201,890
Closed -$4.13M
ZYNE
3239
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-33,364
Closed -$155K
FZT.U
3240
DELISTED
FAST Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
FZT.U
– –
-600,000
Closed -$5.96M
ANZUU
3241
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
– –
-1,240,890
Closed -$12.4M
DTOCU
3242
DELISTED
Digital Transformation Opportunities Corp. Units
DTOCU
– –
-900,000
Closed -$8.89M
RCLFU
3243
DELISTED
Rosecliff Acquisition Corp I Unit
RCLFU
– –
-971,060
Closed -$9.63M
BKI
3244
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-32,594
Closed -$2.41M
FOCS
3245
DELISTED
Focus Financial Partners Inc. Class A
FOCS
– –
-294,863
Closed -$12.3M
AURCU
3246
DELISTED
Aurora Acquisition Corp. Unit
AURCU
– –
-765,000
Closed -$7.92M
LTCH
3247
DELISTED
Latch, Inc. Common Stock
LTCH
– –
-16,372
Closed -$178K
CPUH.U
3248
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
– –
-500,949
Closed -$5.05M
PMGMU
3249
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
– –
-301,005
Closed -$2.99M
SDACU
3250
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
– –
-119,481
Closed -$1.19M
128 129
130
131 132

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.